ArticleInternational immunology2019

A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection.

Takuya Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.